How should I evaluate and treat an adult with an elevated thyroid‑stimulating hormone (TSH) level?

Evaluation and Treatment of Elevated TSH in Adults

For adults with elevated TSH, first confirm the diagnosis with repeat testing in 2-3 months, then measure free T4 to distinguish between overt and subclinical hypothyroidism—treatment decisions depend critically on TSH level, age, symptoms, and cardiac comorbidities. 1

Initial Diagnostic Approach

Confirm the Elevation

• Repeat TSH measurement 2-3 months after initial finding 2, 3
  • Up to 62% of elevated TSH levels normalize spontaneously 3
  • Include thyroid peroxidase antibody (TPOAb) testing at reassessment 2
  • Obtain morning samples for accuracy 4

Measure Free T4 Simultaneously

This critical step localizes the problem:

• Low TSH + Low free T4 = Central hypothyroidism (pituitary/hypothalamic problem) 4
  • Requires evaluation for hypophysitis
  • Must give hydrocortisone before thyroid hormone if adrenal insufficiency suspected 1
• High TSH + Low free T4 = Overt primary hypothyroidism
• High TSH + Normal free T4 = Subclinical hypothyroidism

Rule Out Spurious Results

Before treating, exclude:

• Macro-TSH (TSH-antibody complexes causing falsely elevated readings) 5
• Heterophilic antibodies 1
• Recovery phase from nonthyroidal illness (TSH may rise to <20 mIU/L) 1
• Adrenal insufficiency (TSH normalizes with glucocorticoid alone) 1
• Medications: dopamine, high-dose glucocorticoids suppress TSH 1

Treatment Algorithm by TSH Level and Patient Characteristics

Overt Hypothyroidism (Elevated TSH + Low Free T4)

Always treat. Levothyroxine dosing strategy:

Young healthy adults (<50-60 years, no cardiac disease):

• Start full replacement: ~1.6 mcg/kg/day based on ideal body weight 4, 1
• Can begin at 50-75 mcg daily 1

Older adults (>50-60 years) without coronary disease:

• Start 50 mcg daily 1

Patients with coronary heart disease:

• Start 12.5-25 mcg daily 1
• Monitor closely for anginal symptoms 1
• Titrate slowly to avoid cardiac complications

Elderly/frail with multiple comorbidities:

• Start 25-50 mcg daily 4
• Require 20-25% less per kilogram than younger patients 1

Subclinical Hypothyroidism (Elevated TSH + Normal Free T4)

Treatment is NOT routinely recommended for most adults, with specific exceptions 6, 3:

TSH 4.5-10 mIU/L (or 6.8-10 mIU/L by Korean criteria):

• Do NOT treat routinely 7, 6, 3
• Monitor TSH every 6-12 months 7
• High-quality evidence shows no clinically relevant benefits for quality of life, thyroid symptoms, depression, fatigue, or BMI 6

Consider treatment ONLY if:

• Age <65 years with TSH persistently >7-10 mIU/L AND coronary artery disease or heart failure 2, 3
• Concurrent dyslipidemia in younger adults 2
• Attempting pregnancy (see below)

TSH >10 mIU/L:

• Treatment is reasonable in adults <70 years 4, 7
• Start 25-75 mcg levothyroxine depending on TSH degree 1
• 5% annual progression rate to overt hypothyroidism 7

Elderly patients (≥70 years):

• Generally do NOT treat regardless of TSH level 2, 3
• TSH naturally increases with age (97.5th percentile is 7.5 mIU/L at age >80) 3
• Treatment may be harmful in elderly with subclinical hypothyroidism 3

Special Populations

Pregnancy or planning conception:

• Treat if TSH elevated, regardless of level 7
• Target TSH <2.5 mIU/L in first trimester 1
• Target TSH <3.0 mIU/L in second trimester 1
• Target TSH <3.5 mIU/L in third trimester 1
• Monitor TSH every 4 weeks during first half of pregnancy 1
• Increase levothyroxine dose by ~30% immediately upon conception 1

Immune checkpoint inhibitor therapy:

• Monitor TSH every 4-6 weeks in asymptomatic patients 4
• Grade 1 (TSH 4.5-10 mIU/L, asymptomatic): Continue therapy, monitor 4
• Grade 2 (TSH persistently >10 mIU/L or symptomatic): Start levothyroxine 4
• May represent recovery phase of thyroiditis—monitor 3-4 weeks before treating if free T4 normal 4

Levothyroxine Administration

Critical for absorption:

• Take with water 30-60 minutes before breakfast OR at bedtime 4 hours after last meal 1
• Never with food, coffee, or interfering medications 1
• Store at 20-25°C, protected from light and moisture 1

Medications/substances that impair absorption (separate by 4+ hours):

• Calcium, iron, multivitamins
• Proton pump inhibitors
• Bile acid sequestrants
• Soy products
• Fiber supplements

Monitoring and Titration

Initial monitoring:

• Recheck TSH 4-8 weeks after starting or adjusting dose 1
• Adjust in increments of 12.5-25 mcg 1

Target TSH for treatment:

• Within normal reference range (0.45-4.12 mIU/L) for non-pregnant adults 1
• No evidence supports targeting low-normal TSH 1
• Free T4 should normalize when TSH normalizes 1

Long-term monitoring:

• Once stable: TSH every 6-12 months 1
• Recheck 4-8 weeks after starting medications affecting absorption or metabolism 1

Critical Pitfalls to Avoid

1. Overtreatment occurs in 20% of patients 1—causes atrial fibrillation (especially elderly), bone loss (postmenopausal women), cardiovascular complications 1

2. Non-compliance is the most common cause of persistently elevated TSH on high doses (>200 mcg/day) 1—consider weekly dosing if compliance is problematic 1

3. Never start thyroid hormone before ruling out adrenal insufficiency in central hypothyroidism 1—can precipitate adrenal crisis

4. Do not treat based on symptoms alone without biochemical confirmation 1

5. Recovery phase thyroiditis can cause transient TSH elevation—wait 3-4 weeks if free T4 remains normal 4

When to Consult Endocrinology

Refer for 1:

• Difficulty achieving or maintaining euthyroid state
• Pregnancy or planning conception
• Cardiac disease complicating treatment
• Goiter, nodules, or structural thyroid changes
• Other endocrine disorders (adrenal, pituitary)
• Central hypothyroidism
• Unusual thyroid function test patterns
• Children and infants